@article {3676,
	title = {Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.},
	journal = {The New England journal of medicine},
	volume = {369},
	year = {2013},
	month = {2013 Oct 31},
	pages = {1715-25},
	abstract = {The cost-effectiveness of early antiretroviral therapy (ART) in persons infected with human immunodeficiency virus (HIV) in serodiscordant couples is not known. Using a computer simulation of the progression of HIV infection and data from the HIV Prevention Trials Network 052 study, we projected the cost-effectiveness of early ART for such persons.},
	keywords = {Adult, Anti-Retroviral Agents, Cost-Benefit Analysis, Disease Transmission, Infectious, Drug Administration Schedule, Female, Gross Domestic Product, Health Care Costs, HIV Infections, Humans, India, Male, South Africa},
	issn = {1533-4406},
	doi = {10.1097/ADM.0b013e3182a3b603},
	author = {Walensky, Rochelle P and Ross, Eric L and Kumarasamy, Nagalingeswaran and Wood, Robin and Noubary, Farzad and Paltiel, A David and Nakamura, Yoriko M and Godbole, Sheela V and Panchia, Ravindre and Sanne, Ian and Weinstein, Milton C and Losina, Elena and Mayer, Kenneth H and Chen, Ying Q and Wang, Lei and McCauley, Marybeth and Gamble, Theresa and Seage, George R and Cohen, Myron S and Freedberg, Kenneth A}
}
